The Development of the Pediatric Migraine Action Plan (PedMAP)
- PMID: 31710107
- PMCID: PMC7316640
- DOI: 10.1111/head.13666
The Development of the Pediatric Migraine Action Plan (PedMAP)
Keywords: Pediatric Migraine Action Plan; migraine.
Conflict of interest statement
Scott B. Turner No COI
Elizabeth K. Rende No COI
Christina L. Szperka COI: Pfizer, Allergan, NIH
Andrew D. Hershey COI: NIH, MRF, Alder, Amgen, Lilly, Teva, Biohaven, Curelator, Electrocore, Theranica, Depomed, Impax
References
-
- Orr SL, Kabbouche MA, O’Brien HL, Kacperski J, Powers SW, Hershey AD. Paediatric migraine: evidence-based management and future directions. Nature Rev Neurol. 2018;14(9):515–527. - PubMed
-
- Centers for Disease Control and Prevention (2016). Health Literacy: Guidance and Tools. Retrieved 3/29/19 at https://www.cdc.gov/healthliteracy/developmaterials/guidancestandards.html
-
- Asthma and Allergy Foundation of America . Asthma Action Plan. Retrieved 4/12/19 at https://www.aafa.org/media/1601/asthma-action-plan-aafa.pdf
-
- Cincinnati Children’s Hospital Medical Center . Headache Center. PedMIDAS Tool. Retrieved 11/23/18 at https://www.cincinnatichildrens.org/service/h/headache-center/pedmidas
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
